©The Author(s) 2026.
World J Psychiatry. Jan 19, 2026; 16(1): 112139
Published online Jan 19, 2026. doi: 10.5498/wjp.v16.i1.112139
Published online Jan 19, 2026. doi: 10.5498/wjp.v16.i1.112139
Table 3 Comparison of serum serotonin and norepinephrine levels before and after treatment between groups, mean ± SD
| Group | Cases | Serotonin (ng/L) | T value | P value | Norepinephrine (ng/L) | T value | P value | ||
| Pre-treatment | Post-treatment | Pre-treatment | Post-treatment | ||||||
| Control | 46 | 324.31 ± 30.84 | 582.18 ± 41.93 | 33.601 | 0.000 | 92.28 ± 10.34 | 195.23 ± 21.09 | 29.727 | 0.000 |
| Study | 46 | 324.08 ± 31.72 | 649.71 ± 52.33 | 36.091 | 0.000 | 92.41 ± 10.22 | 218.07 ± 23.19 | 33.630 | 0.000 |
| T value | 0.035 | 6.830 | 0.061 | 4.941 | |||||
| P value | 0.972 | 0.001 | 0.952 | 0.001 | |||||
- Citation: Xu MY, Lu Y, Shi GM, Yao J, Ding CQ, Zhou RJ. Clinical efficacy and effects on hypothalamic-pituitary-adrenal axis function of proscar combined with selective serotonin reuptake inhibitor in post-stroke depression. World J Psychiatry 2026; 16(1): 112139
- URL: https://www.wjgnet.com/2220-3206/full/v16/i1/112139.htm
- DOI: https://dx.doi.org/10.5498/wjp.v16.i1.112139